iShares Genomics Immunology and Healthcare ETF (IDNA)

NYSEARCA: IDNA · IEX Real-Time Price · USD
-0.71 (-2.23%)
Aug 19, 2022 4:00 PM EDT - Market closed
Assets $203.71M
NAV $32.34
Expense Ratio 0.47%
PE Ratio 10.85
Shares Out 6.30M
Dividend (ttm) $0.39
Dividend Yield 1.23%
Ex-Dividend Date Jun 9, 2022
1-Year Return -38.71%
Volume 24,816
Open 31.30
Previous Close 31.77
Day's Range 30.98 - 31.48
52-Week Low 24.77
52-Week High 55.55
Beta 0.83
Holdings 52
Inception Date Jun 11, 2019

About IDNA

The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.

Asset Class Equity
Region Global
Issuer BlackRock iShares
Stock Exchange NYSEARCA
Ticker Symbol IDNA
Index Tracked NYSE FactSet Global Genomics and Immuno Biopharma Index

Top 10 Holdings

41.08% of assets
Name Symbol Weight
Beam Therapeutics BEAM 5.20%
BEIGENE LTD 6160.HK 4.61%
Intellia Therapeutics NTLA 4.29%
Fate Therapeutics FATE 4.20%
Moderna MRNA 4.03%
Twist Bioscience TWST 3.78%
Gilead Sciences GILD 3.64%
Blueprint Medicines BPMC 3.60%
Exelixis EXEL 3.54%
View More Holdings


Ex-Dividend Amount Pay Date
Jun 9, 2022 $0.1359 Jun 15, 2022
Dec 13, 2021 $0.25636 Dec 17, 2021
Jun 10, 2021 $0.05215 Jun 16, 2021
Dec 14, 2020 $0.03621 Dec 18, 2020
Jun 15, 2020 $0.08367 Jun 19, 2020
Dec 16, 2019 $0.23706 Dec 20, 2019
Full Dividend History


7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher

Monkeypox stocks, our topic for today, have had a mostly mixed performance so far in 2022. It is likely, however, that they could benefit from the similar tailwinds enjoyed by companies, such as Pfizer ...


A Comprehensive Guide to Genomic ETFs

Genomic ETFs are expected to benefit from the favorable trends in the genomic editing space.

Biotech ETFs Slip After Novavax Cuts 2022 Guidance

Biotechnology sector-related exchange traded funds retreated with Novavax Inc. (NasdaqGS: NVAX), plunging after the vaccine developer cut its 2022 revenue guidance in half. On Tuesday, the iShares Genom...

Other symbols: GERMSBIOXBI

Top ETFs Tracking CRISPR Gene Editing

These ETFs give you exposure to CRISPR gene editing without having to pick individual stocks.


BlackRock Releases Megatrends Report

What to consider for thematic ETFs in 2022 and beyond.



Join us for a triple-header to determine the best genomics biotech ETF!

Other symbols: ARKGGNOM

Take a Look at the Top-Performing Biotech ETFs YTD

The pandemic has triggered a race to introduce vaccines and treatment options, opening up investment opportunities in the biotech sector.

Other symbols: BBHBIBIBBIEIH

How Are Genomics ETFs Responding to Q2 Earnings?

Let's take a look at some big genomics earnings releases to see if these will impact ETFs exposed to the space.

9 Best Biotech ETFs to Play High-Octane Trends

Biotechnology is a dynamic but often volatile industry. These biotech ETFs provide a lower-risk way to invest in the space.

Genomics ETFs Surge on a Major Breakthrough in CRISPR Study

The genomic-editing space has come under the spotlight with the release of encouraging data from a study assessing an in vivo CRISPR-based gene editing therapy candidate, NTLA-2001.

Other symbols: ARKGGNOM

Dig Deep: The Market Megatrends You Cannot Afford to Miss

As investors re-allocate in 2021, it is critical to look past the headlines to the overarching themes that will propel our economy into the future. Investors cannot afford to miss developments like digi...

Other symbols: IRBO

Best Biotech ETFs for Q2 2021

The best biotech ETFs for Q2 2021 are ARKG, IDNA, and XBI.

Other symbols: ARKGXBI

Top-Performing Biotech ETFs Amid the COVID-19 Crisis

The coronavirus pandemic triggered a race to introduce vaccine and treatment, thereby opening up new investing opportunities in the biotech sector in 2020.


Megatrends To Invest In Now: 3 Best ETF Picks

BlackRock has identified five big trends that are here to stay for the long haul. Investors can get exposure to these drivers via 17 iShares ETFs.

Other symbols: ICLNIDRV

Go Beyond Trends: Healthcare Megatrends with the IDNA ETF

ETF investors looking ahead to 2021 tend to seek out current trends, but the megatrends run much deeper. These are the large-scale undercurrents that can disrupt a whole sector.

Best Biotech ETFs for Q1 2021

The best biotech ETFs for Q1 2021 are ARKG, BTEC, and IDNA.

Other symbols: ARKGBTEC

ETF Strategies to Tap into Medical Breakthroughs, Healthcare Innovations

The election year and the coronavirus has highlighted the importance of an adaptive health industry that meets up with quickly changing times. Investors can also tap into this evolution in healthcare th...

Other symbols: IBB

Why You Should Invest in Genomics ETFs

Genomics ETFs have surged of late; here's why

Other symbols: ARKGGNOM

Genomics ETFs Surge on Nobel Prize for Gene-Editing Pioneers

The announcement of the 2020 Nobel Prize winners for Chemistry has successfully brought investor attention to the gene-editing space.

Other symbols: ARKGGNOMPBE

Healthcare ETFs, Stocks That Gained Double Digits Last Week

The healthcare sector defied last week's market rout buoyed by the progress in the development of a coronavirus vaccine or treatment, and merger and acquisition news.


Moderna ETFs to Gain on New Positive COVID-19 Vaccine Data

Per the latest data from an early stage clinical trial, Moderna's experimental coronavirus vaccine is successfully producing neutralizing antibodies and T-cells in older adults.


Why Small-Cap Biotech ETFs Are Good Long-Term Bets

Small-cap biotech ETFs may prove to be winning bets with or without coronavirus.

Other symbols: BBCBTEC

Moderna Inches Closer to Coronavirus Vaccine: ETFs to Shine

Moderna plans to begin the Phase 3 study of mRNA-1273 this month.

Top-Performing Biotechnology ETFs Amid Coronavirus Outbreak

From vaccine-related progress to development of cell therapies for the treatment of coronavirus, all kept the rally in the biotech sector alive.

Other symbols: ARKGBIBXBI

Invest in the Future With Megatrend ETFs

In this episode of ETF Spotlight, I speak with Jeff Spiegel, U.S. Head of Megatrends and International ETFs at BlackRock, about megatrend investing.